Back to KRYS
Redmile Group, LLC KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
4
Latest value
$175.5M
Q3 2026
Peak value
$234.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $167.1M |
| Q1 2026 | $174M |
| Q2 2026 | $234.9M |
| Q3 2026 | $175.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $175.5M | 527.7K | — | — |
| Q2 2026 | $234.9M | 632.0K | — | — |
| Q1 2026 | $174M | 673.5K | — | — |
| Q4 2025 | $167.1M | 677.7K | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$960.7M
$857.3M
$814.4M
$774.3M